An intranasal ASO therapeutic targeting SARS-CoV-2.
Zhu C, Lee JY, Woo JZ, Xu L, Nguyenla X, Yamashiro LH, Ji F, Biering SB, Van Dis E, Gonzalez F, Fox D, Wehri E, Rustagi A, Pinsky BA, Schaletzky J, Blish CA, Chiu C, Harris E, Sadreyev RI, Stanley S, Kauppinen S, Rouskin S, Näär AM.
Zhu C, et al. Among authors: rouskin s.
Nat Commun. 2022 Aug 3;13(1):4503. doi: 10.1038/s41467-022-32216-0.
Nat Commun. 2022.
PMID: 35922434
Free PMC article.